Larvol Delta - Feasibility-of-Aumolertinib-followed-by-SRT-in-EGFR-NSCLC-Patients-with-Intracranial-OligoProgression-A-Phase-II-Prospective-Study

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

https://amportal.astro.org/sessions/qp-38-22861/feasibility-of-aumolertinib-followed-by-srt-in-egfr-nsclc-patients-with-intracranial-oligo-pr-113778

Huiting Li, MD

May 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next